CSF proteomics analysis to investigate the pharmacodynamic response of the S2R modulator CT1812 in Alzheimer’s disease patients from the SPARC clinical trial

Alzheimer's & Dementia(2022)

引用 0|浏览11
暂无评分
关键词
s2r modulator ct1812,alzheimers disease,proteomics,pharmacodynamic response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要